Mesoblast Stock Market Value
| MESO Stock | USD 13.55 0.27 2.03% |
| Symbol | Mesoblast |
Mesoblast Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesoblast. If investors know Mesoblast will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesoblast listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.05) | Revenue Per Share | Quarterly Revenue Growth (0.41) | Return On Assets | Return On Equity |
The market value of Mesoblast is measured differently than its book value, which is the value of Mesoblast that is recorded on the company's balance sheet. Investors also form their own opinion of Mesoblast's value that differs from its market value or its book value, called intrinsic value, which is Mesoblast's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesoblast's market value can be influenced by many factors that don't directly affect Mesoblast's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesoblast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesoblast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesoblast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mesoblast 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mesoblast's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mesoblast.
| 12/16/2024 |
| 03/16/2025 |
If you would invest 0.00 in Mesoblast on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Mesoblast or generate 0.0% return on investment in Mesoblast over 90 days. Mesoblast is related to or competes with Lipocine, Connect Biopharma, Acumen Pharmaceuticals, Eton Pharmaceuticals, Nuvation Bio, Eledon Pharmaceuticals, and Fennec Pharmaceuticals. Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapor... More
Mesoblast Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mesoblast's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mesoblast upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.42 | |||
| Information Ratio | 0.0814 | |||
| Maximum Drawdown | 49.53 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 13.29 |
Mesoblast Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mesoblast's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mesoblast's standard deviation. In reality, there are many statistical measures that can use Mesoblast historical prices to predict the future Mesoblast's volatility.| Risk Adjusted Performance | 0.0676 | |||
| Jensen Alpha | 0.5937 | |||
| Total Risk Alpha | 1.36 | |||
| Sortino Ratio | 0.1313 | |||
| Treynor Ratio | 0.4218 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mesoblast's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Mesoblast Backtested Returns
Mesoblast appears to be slightly risky, given 3 months investment horizon. Mesoblast has Sharpe Ratio of 0.0585, which conveys that the firm had a 0.0585 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Mesoblast, which you can use to evaluate the volatility of the firm. Please exercise Mesoblast's Downside Deviation of 4.42, risk adjusted performance of 0.0676, and Mean Deviation of 4.43 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Mesoblast holds a performance score of 4. The company secures a Beta (Market Risk) of 1.12, which conveys a somewhat significant risk relative to the market. Mesoblast returns are very sensitive to returns on the market. As the market goes up or down, Mesoblast is expected to follow. Please check Mesoblast's potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether Mesoblast's current price movements will revert.
Auto-correlation | -0.43 |
Modest reverse predictability
Mesoblast has modest reverse predictability. Overlapping area represents the amount of predictability between Mesoblast time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mesoblast price movement. The serial correlation of -0.43 indicates that just about 43.0% of current Mesoblast price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.43 | |
| Spearman Rank Test | -0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 4.69 |
Mesoblast lagged returns against current returns
Autocorrelation, which is Mesoblast stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mesoblast's stock expected returns. We can calculate the autocorrelation of Mesoblast returns to help us make a trade decision. For example, suppose you find that Mesoblast has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mesoblast regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mesoblast stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mesoblast stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mesoblast stock over time.
Current vs Lagged Prices |
| Timeline |
Mesoblast Lagged Returns
When evaluating Mesoblast's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mesoblast stock have on its future price. Mesoblast autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mesoblast autocorrelation shows the relationship between Mesoblast stock current value and its past values and can show if there is a momentum factor associated with investing in Mesoblast.
Regressed Prices |
| Timeline |
When determining whether Mesoblast offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesoblast's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesoblast Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesoblast Stock:
Check out Mesoblast Correlation, Mesoblast Volatility and Mesoblast Alpha and Beta module to complement your research on Mesoblast. To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Mesoblast technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.